Skip to content
Disclosery

13F-HR filed by Ishara Investments LP

Ishara Investments LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 41 holding rows worth $136,099,277.

Accession
0002111609-26-000004
Filer
CIK 2111609
Filed
2026-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 41 entries on the cover page, a total value of $136,099,277 stated on the cover page (in dollars after the unit check, H1), rows summing to $136,099,277 with VALUE read as dollars as filed, 13F file number 028-26490. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ACADIA PHARMACEUTICALS INC004225108COM410,000$10,373,000dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM1,230,000$9,741,600dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM143,500$8,211,070dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW22,550$7,549,515dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM205,000$6,844,950dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM164,000$6,086,040dollars as filed
INSMED INC COM PAR $.01457669307Stock51,250$5,464,275dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock143,500$5,369,770dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK1,025,000$4,971,250dollars as filed
VAXCYTE INC COM92243G108Stock82,000$4,766,660dollars as filed
ANNEXON INC03589W102COM820,000$4,682,200dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM82,000$4,658,420dollars as filed
TONIX PHARMACEUTICALS HOLDIN890260839COMMON STOCK338,250$4,316,070dollars as filed
BRIDGEBIO PHARMA INC10806X102COM57,400$4,275,152dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock16,400$4,014,228dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock205,000$3,359,950dollars as filed
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK1,271,000$3,050,400dollars as filed
KURA ONCOLOGY INC COM50127T109Stock276,750$3,035,948dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS184,500$3,025,800dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share102,500$2,815,675dollars as filed
CYTOKINETICS INC23282W605COM NEW32,800$2,794,232dollars as filed
MINERALYS THERAPEUTICS INC603170101COM102,500$2,765,450dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS55,350$2,434,847dollars as filed
NUVATION BIO INC COM CL A67080N101Stock369,000$2,095,920dollars as filed
WAVE LIFE SCIENCES LTD SHSY95308105Stock328,000$1,905,680dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK26,650$1,860,437dollars as filed
SCHOLAR ROCK HLDG CORP80706P103COM30,750$1,691,250dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock32,800$1,664,600dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock5,125$1,542,779dollars as filed
BEAM THERAPEUTICS INC07373V105COM41,000$1,407,120dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK123,000$1,350,540dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM123,000$1,332,090dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK36,900$1,250,541dollars as filed
Vertex Pharmaceuticals Incorporated92532F100COM2,460$1,221,956dollars as filed
ARS PHARMACEUTICALS INC82835W108COM143,490$1,149,355dollars as filed
MONOPAR THERAPEUTICS INC61023L207COMMON STOCK12,300$1,138,857dollars as filed
ERASCA INC COM29479A108Stock41,000$751,120dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK10,250$439,828dollars as filed
IMMATICS N.VN44445109SHS30,750$311,498dollars as filed
MEREO BIOPHARMA GROUP PLC589492107CMN768,750$244,232dollars as filed
GOSSAMER BIO INC COM38341P102Stock820,000$134,972dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002111609-26-000004this filing2026-08-14acceptance time not in the bulk data set